The sandbox: Parker Institute throws its research muscle behind gene therapy tech for destroying cancer cells
A fantastic article in Endpoint News about the collaboration between PsiOxus and the Parker Institute for Cancer Immunotherapy.
Recent Posts
- Priya Mande, PsiOxus COO, listed in the Top 25 Women Leaders in Biotechnology for 2020
- PsiOxus Therapeutics Announces Clinical Trial with Third Cancer Gene Therapy Treatment and Appointment of New Chief Medical Officer
- PsiOxus Therapeutics Announces First-in-Human Dosing of their Second Gene Therapy Cancer Treatment.
- PsiOxus Therapeutics to Collaborate with the Parker Institute for Cancer Immunotherapy
- PsiOxus Therapeutics Receives $15 Million Milestone Payment as Armed Oncolytic Virus Licensed to Bristol-Myers Squibb Achieves CTA
Comments are closed.